Ovarian stimulation with buserelin/HMG/HCG: prospective randomized study of short versus long protocol.


The combined administration of the gonadotrophin-releasing hormone (GnRH) agonist buserelin and human menopausal gonadotrophin (HMG) was evaluated in 527 cycles (428 patients) of an assisted reproduction programme. All women were randomly allocated according to the ovulation induction protocol into two groups: group I (short protocol; 318 cycles) was given… (More)


  • Presentations referencing similar topics